Loss Causation and Rule 10b-5 Damages After Dura

15 December 2005
By Dr. Marcia Kramer Mayer

Dr. Marcia Kramer Mayer is an expert in the areas of securities and finance. Over the last 13 years she has consulted on damages and related issues in more than 200 shareholder class actions.

On 13 December 2005, Dr. Mayer delivered this presentation in a litigation series teleconference and live audio webcast, hosted by the American Bar Association, that addressed the Dura Pharmaceuticals decision on loss causation in securities class actions as it affects pleading, summary judgment, and damages.

To learn more, please contact Dr. Mayer .